Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) is a publicly traded Healthcare sector company. As of July 5, 2026, TEVA trades at $34.64 with a market cap of $40.34B and a P/E ratio of 25.29. TEVA moved +3.32% today. Year to date, TEVA is +10.53%; over the trailing twelve months it is +103.17%. Its 52-week range spans $12.47 to $37.35. Analyst consensus is strong buy with an average price target of $42.38. Rallies surfaces TEVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TEVA moved +3.32% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $34.64 |
| Market Cap | $40.34B |
| P/E Ratio | 25.29 |
| EPS | $1.37 |
| Dividend Yield | 0.09% |
| 52-Week High | $37.35 |
| 52-Week Low | $12.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $14.14B |
| Net Income | $1.57B |
| Gross Margin | 63.90% |
9 analysts cover TEVA: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.38.